Ligand profile
ILP
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_05467 — Diaminobutyrate--2-oxoglutarate aminotransferase
Identifiers
Database identifiers and provenance.
- Ligand ID
ILP- PDB
5wyf- UniProt (similar protein)
M1GRN3- Target protein
- KP13_05467
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 149.2
- −1 ≤ LogP ≤ 5 1.29
- MW ≤ 500 Da 362.3
- LogP ≤ 5 1.29
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 9
- TPSA ≤ 140 Ų 149.2
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC[C@H](C)[C@H](C(=O)O)NCc1c(cnc(c1O)C)COP(=O)(O)OCC[C@H](C)[C@H](C(=O)O)NCc1c(cnc(c1O)C)COP(=O)(O)O
InChI=1S/C14H23N2O7P/c1-4-8(2)12(14(18)19)16-6-11-10(7-23-24(20,21)22)5-15-9(3)13(11)17/h5,8,12,16-17H,4,6-7H2,1-3H3,(H,18,19)(H2,20,21,22)/t8-,12+/m0/s1InChI=1S/C14H23N2O7P/c1-4-8(2)12(14(18)19)16-6-11-10(7-23-24(20,21)22)5-15-9(3)13(11)17/h5,8,12,16-17H,4,6-7H2,1-3H3,(H,18,19)(H2,20,21,22)/t8-,12+/m0/s1
GZZDWFDWHXPWJK-QPUJVOFHSA-NGZZDWFDWHXPWJK-QPUJVOFHSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00202
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand ILP →
- PDB RCSB structure 5wyf →
- UniProt UniProt M1GRN3 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ILP”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_05467.
PDB 7
Ligands co-crystallized with this protein (structural evidence).
ZINC 35
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).